Accessibility Menu
Paion Ag logo

Paion Ag(FRA) PA8

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
N/A

Paion Ag Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Sep 2, 2026

PA8 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Paion Ag

Paion AG operates as a specialized pharmaceutical entity, concentrating its efforts on creating and selling groundbreaking treatments within the realms of anesthesia, intensive care, and critical care medicine. The company places particular importance on quickly-acting sedatives and other hospital-specific items.

Products and Services
  • Innovative anesthetic agents for surgical procedures
  • Rapid-acting sedatives for intensive care units
  • Specialized medications for critical care environments
Growth Outlook
  • Focus on expanding product portfolio in anesthesia and critical care
  • Potential for increased market share in European healthcare
  • Strategic partnerships may enhance research and development capabilities
Financial Highlights
  • Market capitalization stands at approximately €342 million
  • Trailing twelve months (TTM) revenue of €4.2 million
  • Current ratio of 1.41 indicates strong short-term financial health
Paion AG is positioned within the healthcare sector, specifically in the drug manufacturing industry, focusing on specialty and generic medications. The company has a dedicated workforce of 151 employees and is headquartered in Aachen, Germany. With a market capitalization of around €342 million, Paion AG is actively trading and has shown resilience in its financial metrics. The current ratio of 1.41 suggests that the company is well-equipped to meet its short-term obligations, while the TTM revenue of €4.2 million reflects ongoing operational activities. The emphasis on innovative products in anesthesia and critical care positions Paion AG favorably for future growth, particularly as healthcare demands evolve.
AI Generated • Aug 12, 2026

Industry

Biotechnology

Sector

Health Care

Employees

70

CEO

Gregor Siebert

Website

paion.com

Headquarters

Aachen, NW 40213, DE

PA8 Financials

Key Financial Metrics (TTM)

Gross Margin

94.10%

Operating Margin

4.53%

Net Income Margin

-1.74%

Return on Equity

-8.51%

Return on Capital

N/A

Return on Assets

-1.52%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

€31.29M

Operating Income

€1.51M

EBITDA

€4.31M

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Paion Ag Performance Analysis

Paion Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31EUR 7,128,365N/A
20222022-12-31EUR 33,248,000366.4%
Paion Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31EUR -3.11N/A
20222022-12-31EUR -0.08-97.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ACB.TOAurora Cannabis Inc.
CA$5.63+1.08%
CBGLCannabis Global Inc.
$0.00-50.00%
CURLFCuraleaf Holdings, Inc.
$9.70+0.41%
HCMHUTCHMED (China) Limited
$12.12-2.10%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$71.92+0.00%
WETOWetour Robotics
$5.48-0.04%
INTCIntel
$89.51+0.00%
NVDANvidia
$220.78+0.01%

Questions About PA8

What is the current price of Paion Ag?

Paion Ag is trading at N/A per share.

What is the 52-week range for Paion Ag?

Over the past 52 weeks, Paion Ag has traded between N/A and N/A.

How much debt does Paion Ag have?

As of the most recent reporting period, Paion Ag reported total debt of €20.35M.

How much cash does Paion Ag have on hand?

Paion Ag reported €10.63M in cash and cash equivalents in its most recent financial results.

What is Paion Ag’s dividend yield?

Paion Ag does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services